Moneycontrol PRO

you are here: HomeNewsBusinessStocksPrefer Sun Pharmaceutical, Lupin: Jitendra Sriram

SHOW NAMES

Trending Topics

business

Prefer Sun Pharmaceutical, Lupin: Jitendra Sriram

Jitendra Sriram, MD & Head of Research of HSBC India is of the view that one may prefer Sun Pharmaceutical and Lupin from the pharma space.

first published: Sep 18, 2013 11:23 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live
Will Rupee Slide & Expiry Day Caution Keep Nifty Bulls On The Back Foot? | Opening Bell Live
Sensex, Nifty Retreat After Hitting Fresh Highs As Rupee Drops To Record Low| Closing Bell Live
Will Solid Q2 GDP Set The Ball Rolling For Nifty Bulls To Cross 26,300 Decisively?|Opening Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347